STOCK TITAN
  1. Home
  2. Sec-filings
  3. ANIP
  4. [8-K] ANI Pharmaceuticals, Inc. Reports Material Event

[8-K] ANI Pharmaceuticals, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ANIP logo
Ani Pharmaceutic

NASDAQ:ANIP

ANIP Rankings

#3170 Ranked by Market Cap
N/A Ranked by Dividends

ANIP Latest News

Jul 23, 2025
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)
Jul 2, 2025
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
Jun 12, 2025
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
May 27, 2025
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
May 12, 2025
ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

ANIP Latest SEC Filings

Jul 23, 2025
[8-K] ANI Pharmaceuticals, Inc. Reports Material Event
Jul 21, 2025
[Form 4] ANI Pharmaceuticals, Inc. Insider Trading Activity
Jul 14, 2025
[Form 4] ANI Pharmaceuticals, Inc. Insider Trading Activity
Jul 11, 2025
[S-8] ANI Pharmaceuticals, Inc. Employee Benefit Plan Registration
Jul 11, 2025
[S-8] ANI Pharmaceuticals, Inc. Employee Benefit Plan Registration

ANIP Stock Data

1.44B
18.03M
11.22%
97.42%
11.74%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
BAUDETTE